发明名称 |
COMBINATION THERAPY FOR CANCER |
摘要 |
An agent comprises a vector having a functional gene, a prodrug which can be converted into a cytotoxic agent by an expression product of the gene, and another cytotoxic agent,as a combined preparation for simultaneous, sequential or separate use in the therapy of cancer or of a disease characterised by an impaired mismatch repair (MMR) pathway, wherein the dosage regimen comprises beginning the another cytotoxic agent therapy no later than 7 days after the prodrug therapy has finished. |
申请公布号 |
CA2824689(A1) |
申请公布日期 |
2012.07.26 |
申请号 |
CA20122824689 |
申请日期 |
2012.01.18 |
申请人 |
ARK THERAPEUTICS LTD. |
发明人 |
MAATTA, ANN-MARIE;SAMARANAYAKE, HARITHA;PIKKARAINEN, JERE;YLA-HERTTUALA, SEPPO |
分类号 |
A61K38/45;A61K48/00;A61P35/00 |
主分类号 |
A61K38/45 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|